Research & Clinical Trials
Custom Fit Total Knee Replacement using the Triatholon CS Knee: Functional Outcome and Patient Satisfaction. 2007-2012.
Revision Total Hip Arthroplasty using porous coated acetabular components for patients with pelvic bone loss and deformity. 2009-2013.
Clinical Outcome and Recurrence of Soft Tissue Sarcomas: A Review for a Single Institution. 2004- present.
Blood conservation in complex orthopaedic reconstruction surgery using a bipolar hemosealant device. 2008-2011.
Femoral Head Resurfacing in patients under 40 yrs of age: Clinical Outcome and Implant Survival. 2004- present.
A Phase III Randomized Trial of Cryoablation vs. Radiation for the Palliation of Painful Bone Metastases, Multi-center study funded by NCI Cancer Trials Support Unit & North Central Cancer Treatment Group 2008-2009.
Comparing CT-based Structural Rigidity Analysis (SRA) to Current Clinical and Radiological Methods for Selecting Treatment Options for Patients with Skeletal Metastasis, Multicenter study funded by Musculoskeletal Tumor Society 2008-2009.
Sanofi - EFC1042 - A multinational, multicenter, randomized, double-blind study comparing the efficacy and safety of AVE5026 with enoxaparin for the prevention of venous thromboemblolism in patients undergoing elective total hip replacement surgery.
Sanofi - EFC1043 - A multinational, multicenter, randomized, double-blind study comparing the efficacy and safety of AVE5026 with enoxaparin for the prevention of venous thromboembolism in patients undergoing hip fracture surgery.
Sanofi - EFC10571 - A multinational, multicenter, randomized, double-blind study comparing the efficacy and safety of AVE5026 with enoxaprin for the prevention of venous thromboembolism in patients undergoing elective knee replacement surgery.
Pacira - Simple TAK 311 - A phase 3, multicenter, randomized, double-blind, parallel-group, active-control study to evaluate the safety and efficacy of a single intraoperative administration of SKY0402 for prolonged postoperative analgesia in subjects undergoing total knee arthroplasty.
Takeda - TAK-442_201 - A Phase 2, Randomized, Active Comparator-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement.
Bristol-Myers Squibb - CV185-035 - A Phase 3 Randomized, Double-Blind, Active-Controlled (Enoxaparin), Parallel Group, Multi-Center Study to Evaluate the Safety and Efficacy of Oral Apixaban in Subjects Undergoing Elective Total Hip Replacement Surgery.